Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03679923 · ClinicalTrials.gov registry record · NA

NEM® Versus Placebo in Exercised-induced Joint Pain, Stiffness, & Cartilage Turnover in Healthy Men & Women

A NA study, sponsored by ESM Technologies.

Completed
Registry status
NA
Development phase
84
Enrollment target

NCT03679923 is a NA study that has completed, run by ESM Technologies. The registered enrollment target is 84 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03679923, a NA study, has completed, sponsored by ESM Technologies.

COMPLETED
Registry status
NA
Development phase
84 participants
Enrollment target

Study Summary

This study is intended to evaluate the effect of the dietary supplement NEM® brand eggshell membrane versus placebo in reducing exercise-induced joint pain, stiffness \& cartilage turnover in healthy men \& women. Half of the study participants will receive NEM, once daily, orally while the other half of the study participants will receive placebo, once daily, orally while performing an exercise regimen every other day for two weeks.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT NEM® brand eggshell membrane

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2018-09-20
Est. Completion 2018-11-13
Phase NA

Sponsor

ESM Technologies

9 total trials

What the Registry Record Tells You About NCT03679923

The ClinicalTrials.gov registry entry for NCT03679923 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ESM Technologies, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT03679923 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03679923 about?

NCT03679923 is a clinical study titled "NEM® Versus Placebo in Exercised-induced Joint Pain, Stiffness, & Cartilage Turnover in Healthy Men & Women". This study is intended to evaluate the effect of the dietary supplement NEM® brand eggshell membrane versus placebo in reducing exercise-induced joint pain, stiffness \& cartilage turnover in healthy men \& women. Half of the study participants will receive NEM, once daily, orally while the other ha...

What is the current status of trial NCT03679923?

This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2018-09-20. Estimated completion is 2018-11-13.

What interventions are being tested in trial NCT03679923?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), NEM® brand eggshell membrane (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03679923?

This trial is sponsored by ESM Technologies, which has 9 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.